Vaccitech plc - ADR

NASDAQ:VACC  
11.36
-0.31 (-2.66%)
Earnings Announcements

Vaccitech Reports Third Quarter 2021 Financial Results And Recent Corporate Developments

Published: 11/12/2021 12:47 GMT
Vaccitech plc - ADR (VACC) - Vaccitech Reports Third Quarter 2021 Financial Results and Recent Corporate Developments.
Q3 Loss per Share $0.13.
Believes Cash and Cash Equivalents Are Sufficient to Fund Operations Into First Half of 2024.
Q3 Earnings per Share View $-0.45 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.41 Million
Adjusted EPS is expected to be -$0.31

Next Quarter Revenue Guidance is expected to be $5.95 Million
Next Quarter EPS Guidance is expected to be -$0.20

More details on our Analysts Page.